NEW

ETHICON LAUNCHES VISTASEAL FIBRIN SEALANT

Many patients today are entering the operating room with multiple factors that can cause disruptive bleeding during surgery, which can be challenging to manage and potentially dangerous. To help address this, Johnson & Johnson Medical Devices Companies* announced...

Going digital: Using real data to prevent infection

By Dustin Rahlf, Director of Healthcare Digital Solutions at Ecolab While AI & robot enabled surgeries are capturing headlines, real-time digital dashboards and predictive analytics may be the overshadowed sidekick that enables a safer operating room (OR). It is...

AORN Updates Guideline on Sterilization Packaging

By Susan Klacik The primary objective of sterilization packaging is to maintain the sterile integrity of the packaged contents until they are used. Many factors influence this outcome and the Association of periOperative Registered Nurses’ (AORN’s) newly updated...

ASCs Embrace Nation’s Renewed Focus on Healthcare Quality

By Bill Prentice As the Democratic presidential candidates continue to define their plans for delivering affordable, accessible healthcare and members of Congress on both sides of the aisle continue to explore ways to cut the cost of that care without sacrificing...

Fuse Medical Inc. Completes Acquisition of Maxim Surgical

Fuse Medical Inc. announced the completion of the acquisition of Palm Springs Partners LLC d/b/a Maxim Surgical, a manufacturing company in the spinal fusion device market and full-service medical device and distribution company. The effective date of Acquisition was August 1, 2018.

Formed in April 2011, Maxim designs and manufactures spinal interbody spacers and distributes a wide variety of spine, sports medicine and biologics product lines. Inclusive in the Maxim portfolio of spinal implant products is the Maxim Surgical X-Treme Interbody Fusion System that previously received 510(k) clearance from the U.S. Food & Drug Administration. Maxim’s long-term strategy is to bring more innovative spinal implant products to market for retail and wholesale distribution.

“We are very excited that Maxim has become part of the Fuse family. Maxim’s portfolio of products bolsters our strategy of expanding Fuse into medical device design and manufacturing,” Fuse Chief Executive Officer Christopher C. Reeg said. “We believe that integrating Maxim with our operations will enhance Fuse’s earnings immediately and allow us to be even better positioned to meet our customers’ needs.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X